Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$891,413,233
+$266,026,907 QoQ
Shares Held
18,594,352
+9.3% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#2
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $1,754,958,212 across 10 Drug Manufacturers - General names. NVO ranks #1 (50.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
18,594,352 | $891,413,233 | |
| 2 | NVS |
Novartis AG
|
5,239,309 | $821,104,505 | |
| 3 | ABBV |
AbbVie Inc.
|
43,544 | $10,957,411 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
170,634 | $9,831,930 | |
| 5 | MRK |
Merck & Co., Inc.
|
58,514 | $7,519,048 | |
| 6 | LLY |
ELI LILLY & Co
|
5,956 | $7,143,805 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,442 | $5,867,481 | |
| 8 | JNJ |
Johnson & Johnson
|
2,741 | $696,131 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $891,413,233 | 18,594,352 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $625,386,326 | 17,017,315 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $871,848,337 | 17,135,384 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $897,021,818 | 16,165,468 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $867,997,659 | 12,576,031 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $860,239,523 | 12,388,242 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $995,396,429 | 11,571,686 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,026,849,558 | 8,623,915 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,270,020,156 | 8,897,437 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,136,665,108 | 8,852,532 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $931,393,970 | 9,003,325 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $827,354,659 | 9,097,808 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $768,198,271 | 4,746,946 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $776,071,671 | 4,876,660 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $673,964,777 | 4,979,790 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $515,823,265 | 5,177,389 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $592,332,685 | 5,315,738 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $655,544,696 | 5,903,149 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $689,564,736 | 6,156,828 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $618,216,934 | 6,439,089 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $536,308,104 | 6,402,150 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $450,053,782 | 6,675,375 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $476,702,220 | 6,824,656 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $505,420,614 | 7,279,571 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $482,250,836 | 7,364,857 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $989,305,428 | 16,433,645 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||